CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -37.8% | 16,472 | +2.9% | 0.00% | – |
| Q2 2023 | $45 | -42.3% | 16,010 | +0.2% | 0.00% | – |
| Q1 2023 | $78 | -76.6% | 15,979 | -48.4% | 0.00% | – |
| Q4 2022 | $333 | -99.9% | 30,979 | +19.2% | 0.00% | – |
| Q3 2022 | $243,000 | +29.3% | 26,000 | +26.1% | 0.00% | – |
| Q2 2022 | $188,000 | -51.0% | 20,611 | -34.8% | 0.00% | – |
| Q1 2022 | $384,000 | -1.3% | 31,600 | -1.2% | 0.00% | – |
| Q4 2021 | $389,000 | -21.4% | 31,976 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $495,000 | -10.5% | 32,065 | -17.3% | 0.00% | 0.0% |
| Q2 2021 | $553,000 | -33.7% | 38,752 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $834,000 | +43.5% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $581,000 | +18.8% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $489,000 | -25.6% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $657,000 | +29.6% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $507,000 | -18.1% | 38,400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $619,000 | -12.1% | 38,400 | -0.3% | 0.00% | 0.0% |
| Q3 2019 | $704,000 | -7.7% | 38,500 | +8.5% | 0.00% | 0.0% |
| Q2 2019 | $763,000 | +26.7% | 35,500 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $602,000 | +50.9% | 30,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $399,000 | -44.7% | 30,700 | +2.0% | 0.00% | 0.0% |
| Q3 2018 | $721,000 | +25.2% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $576,000 | +54.4% | 30,100 | 0.0% | 0.00% | – |
| Q1 2018 | $373,000 | +1.4% | 30,100 | 0.0% | 0.00% | – |
| Q4 2017 | $368,000 | -10.7% | 30,100 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $412,000 | -11.0% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $463,000 | +0.7% | 30,100 | +20.4% | 0.00% | 0.0% |
| Q1 2017 | $460,000 | +152.7% | 25,001 | +27.6% | 0.00% | – |
| Q4 2016 | $182,000 | +11.0% | 19,600 | 0.0% | 0.00% | – |
| Q3 2016 | $164,000 | +74.5% | 19,600 | 0.0% | 0.00% | – |
| Q2 2016 | $94,000 | -23.0% | 19,600 | 0.0% | 0.00% | – |
| Q1 2016 | $122,000 | -56.1% | 19,600 | +18.8% | 0.00% | – |
| Q4 2015 | $278,000 | +17.8% | 16,500 | 0.0% | 0.00% | – |
| Q3 2015 | $236,000 | +48.4% | 16,500 | +25.9% | 0.00% | – |
| Q2 2015 | $159,000 | – | 13,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |